Recently, Sepax Technologies, Inc. announced that several of its shareholders plan to reduce their stakes in the company by up to 6% of the total shares outstanding, through centralized bidding or block trades. The shareholders involved include certain founding team members and early institutional investors, citing personal capital needs and investment exit arrangements as the primary reasons for the planned divestment. The company emphasized that the减持 will strictly comply with relevant laws and regulations and be completed within the prescribed timeframe.Sepax Technologies is a high-tech enterprise specializing in high-performance liquid chromatography (HPLC) packing materials and separation and purification solutions, with products widely used in biopharmaceuticals, food safety testing, and environmental analysis. Although such shareholder sell-offs may temporarily affect market sentiment, the company maintains solid fundamentals, with consistently improving financial performance and growing R&D capabilities and market share. Industry experts note that this type of divestment is a normal capital market activity and does not reflect a negative outlook on the company’s future.Investors are advised to view the share reduction rationally and focus on the company’s long-term value and sector prospects. Sepase Technologies stated it will continue to prioritize core technology innovation and global expansion to drive high-quality, sustainable growth.
近日，赛分科技（Sepax Technologies, Inc.）发布公告称，公司多名股东计划通过集中竞价或大宗交易方式减持公司股份，合计减持比例不超过公司总股本的6%。此次拟减持的股东包括部分创始团队成员及早期机构投资者，减持原因主要为自身资金需求及投资退出安排。公告强调，本次减持计划将严格遵守相关法律法规，并在规定期限内完成。赛分科技是一家专注于高性能液相色谱填料和分离纯化解决方案的高新技术企业，产品广泛应用于生物医药、食品检测及环境分析等领域。尽管股东减持可能在短期内对市场情绪造成一定影响，但公司基本面稳健，近期业绩持续向好，研发能力与市场份额稳步提升。业内人士指出，此类减持属于正常资本市场行为，不代表对公司未来发展的负面判断。投资者应理性看待股东减持行为，关注公司长期价值与行业前景。赛分科技表示，将继续聚焦核心技术研发与全球化布局，推动高质量可持续发展。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/13105.html